• De Freitas GR, Bogousslavsky J. Primary stroke prevention. Eur J Neurol 2001;8:1-15
• Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29:415–21
• Sudlow CL and Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997;28:491–99
• Fisher M and Schaebitz W. An overview of acute stroke therapy. Past, present, and future. Arch Intern Med 2000;160:3196-206
• Love S. Oxidative stress in brain ischaemia. Brain Pathol 1999;9:119–31
• Cherubini A, Polidori C, Benedetti C, Ercolani S, Senin U, Mecocci P. Association between ischemic stroke and increased oxidative stres. 2nd Virtual Congress of Cardiology - FAC, Argentina, Sep 1-Nov 30,2001
• Re G, Azzimondi G, Lanzarini C, Bassein L, Vaona I, Guarnieri C. Plasma lipoperoxidative markers in ischemic stroke suggest brain embolism. Eur J Emerg Med 1997;4:5–9
• El-Kossi MMH, Zakhary MM. Oxidative Stress in the context of acute cerebrovascular stroke. Stroke 2000;31:1889-97
• Warner DS, Sheng H, Haberle IB. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004;207:3221-31
• Chabrier PE, Auguet M, Spinnewyn B, et al.BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA 1999;96:10824-29
• Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069-75
• Giles WH, Croft JB, Greenlund KJ, et al. Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Stroke 1998;29:2473–77
• Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131:352–55
• Chao CL, Lee YT. Impairment of cerebrovascular reactivity by methioneinduced hyperhomocysteinemia and amelioration by quinapril treatment. Stroke 2000;31:2907–11
• Thambyrajah J, Townend JN. Homocysteine and atherothrombosis — mechanisms for injury. Eur Heart J 2000;21:967–74
• Rosengarten B, Osthaus S, Auch D, Kaps M. Effects of acute hyperhomocysteinemia on the neurovascular coupling mechanism in healthy young adults. Stroke 2003;34:446-51
• Misra HP. Generation of superoxide free radical during the autooxidation of thiols. J Biol Chem 1974;249:2151–55
• Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 1994;105:165–70
• Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004;35:345-47
• Heinecke JW, Rosen H, Suzuki LA, Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low-density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987;262:10098-103
• Teasdale G, Jenett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81–3
• Jenett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975;1:480–4
• Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39: 263–71
• Slater TF: Overview of methods used for detecting lipid peroxidation. Methods Enzimol 1984;105:283-93
• Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995;41: 892-96
• Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol 2001;8:43-8
• Sharp PC, Mulholland C, Trinic KT. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994;163:488–91
• Selakovic VM, Jovanovic MD, Jovicic A. Changes of cortisol levels and index of lipid peroxidation in cerebrospinal fluid of patients in the acute phase of completed stroke. Vojno Pregl 2002;59:485-91
• Watson BD. Evaluation of concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke. Prog Brain Res 1993;96:69–95
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59:1609-23
• Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994;28:221-67
• Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 2000;301:173-87
• Castillo J, Rama R, Dávalos A. Nitric Oxide– Related brain damage in acute ischemic stroke. Stroke 2000;31:852-58
• Shankar R, Zhu J-S, Ladd B, Henry D, Shen H-Q, Baron AD. Central Nervous System Nitric Oxide Synthase Activity Regulates Insulin Secretion and Insulin Action. J Clin Invest 1998;102:1403–12
• Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9
• Serot JM, Béné MC, Faure GC. CSF homocysteine, CSF folates and choroid plexus. Neurobiol Aging 2003;24:627-8
• Jia L, Furchgott RF. Inhibition by sulphydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 1993;267:371-8
• Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with dietinduced hyperhomocysteinemia. J Clin Invest 1996;98:24-9
• Zhang F, Slungaarg A, Vercellotti GM, Iadecola C. Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol 1998;274:1704–11
• Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF. Changes in plasma homocysteine in the acute phase after stroke. Stroke 2002;33: 473–78

Vancouver

Aygül R, Kotan D, Yıldırım A, Ulvi H, Akçay F. PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY. EUR J GEN MED. 2008;5(2):57-63. https://doi.org/10.29333/ejgm/82578

APA

Aygül, R., Kotan, D., Yıldırım, A., Ulvi, H., & Akçay, F. (2008). PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY. European Journal of General Medicine, 5(2), 57-63. https://doi.org/10.29333/ejgm/82578

AMA

Aygül R, Kotan D, Yıldırım A, Ulvi H, Akçay F. PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY. EUR J GEN MED. 2008;5(2), 57-63. https://doi.org/10.29333/ejgm/82578

Chicago

Aygül, Recep, Dilcan Kotan, Abdulkadir Yıldırım, Hızır Ulvi, and Fatih Akçay. "PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY". European Journal of General Medicine 2008 5 no. 2 (2008): 57-63. https://doi.org/10.29333/ejgm/82578

Harvard

Aygül, R., Kotan, D., Yıldırım, A., Ulvi, H., and Akçay, F. (2008). PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY. European Journal of General Medicine, 5(2), pp. 57-63. https://doi.org/10.29333/ejgm/82578

MLA

Aygül, Recep et al. "PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY". European Journal of General Medicine, vol. 5, no. 2, 2008, pp. 57-63. https://doi.org/10.29333/ejgm/82578